A 2026 analysis of hospice and home health valuation multiples across the U.S. market. This report breaks down EBITDA multiples, explains how revenue ties into valuation, compares hospice vs home health trends, and outlines what buyers and sellers need to know in 2026.
Read more
Hospice M&A surged in late 2025, marking the strongest quarter since 2021. Learn what this means for hospice valuation, buyer demand, and selling strategy.
Read more
Discover how hospice valuations are determined and what truly drives your agency’s worth. Learn the factors buyers consider — from EBITDA to compliance — and how Vallexa Advisors helps hospice owners secure premium valuations through expert guidance, national reach, and success-only fees.
Read more
Thinking “how to sell a hospice” or “sell my home health”? Vallexa Advisors guides agency owners step-by-step to maximize value and exit with confidence.
Read more